We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLPH
12651
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$17.1K ﹤0.01%
+42,717
New +$21K
RAIN
12652
CALL
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$17.1K ﹤0.01%
19,800
-17,200
-46% -$18.8K
OGG
12653
CALL
Osisko Gold Group
OGG
$872M
$17.1K ﹤0.01%
5,800
-24,700
-81% -$91.8K
CUE icon
12654
PUT
Cue Biopharma
CUE
$233M
$17K ﹤0.01%
247
+30
+14% +$2.93K
THCH icon
12655
CALL
TH International
THCH
$50.9M
$17K ﹤0.01%
1,880
+1,140
+154% +$13.8K
MBC icon
12656
CALL
MasterBrand
MBC
$1.86B
$17K ﹤0.01%
1,400
-3,800
-73% -$46.6K
MOVE icon
12657
Corvex Inc
MOVE
$324M
$17K ﹤0.01%
141
-287
-67% -$39K
LXFR icon
12658
PUT
Luxfer Holdings
LXFR
$457M
$17K ﹤0.01%
1,300
+800
+160% +$10.1K
MMLP icon
12659
PUT
Martin Midstream Partners
MMLP
$93.9M
$17K ﹤0.01%
+6,100
New +$15.8K
BLFY
12660
DELISTED
Blue Foundry Bancorp
BLFY
$16.9K ﹤0.01%
+2,024
New +$19.2K
ENZ
12661
PUT
DELISTED
Enzo Biochem, Inc.
ENZ
$16.9K ﹤0.01%
12,100
-400
-3% -$603
EPIX
12662
DELISTED
ESSA Pharma
EPIX
$16.9K ﹤0.01%
5,475
-5,408
-50% -$15.6K
EHAB
12663
PUT
DELISTED
Enhabit
EHAB
$16.9K ﹤0.01%
1,500
+200
+15% +$2.52K
RMTI icon
12664
CALL
Rockwell Medical
RMTI
$29.2M
$16.8K ﹤0.01%
810
-960
-54% -$29.2K
SKYH.WS icon
12665
Sky Harbour Group Warrants
SKYH.WS
$11.1M
$16.8K ﹤0.01%
84,180
+17,971
+27% +$4.86K
KMPR icon
12666
PUT
Kemper
KMPR
$1.62B
$16.8K ﹤0.01%
400
-500
-56% -$23.7K
OCG icon
12667
Oriental Culture Holding
OCG
$3.31M
$16.8K ﹤0.01%
7
-5
-42% -$10K
FTCI icon
12668
PUT
FTC Solar
FTCI
$38.7M
$16.8K ﹤0.01%
1,310
-860
-40% -$20.8K
ANIK icon
12669
CALL
Anika Therapeutics
ANIK
$288M
$16.8K ﹤0.01%
900
-36,500
-98% -$757K
NBP
12670
PUT
NovaBridge Biosciences American Depositary Shares
NBP
$227M
$16.8K ﹤0.01%
12,700
+3,500
+38% +$7.69K
HT
12671
PUT
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$16.8K ﹤0.01%
1,700
-10,300
-86% -$78.9K
ENTA icon
12672
PUT
Enanta Pharmaceuticals
ENTA
$383M
$16.8K ﹤0.01%
1,500
+600
+67% +$9.66K
CLPS icon
12673
CLPS Inc
CLPS
$25.8M
$16.7K ﹤0.01%
16,707
-7,400
-31% -$7.75K
SLVP icon
12674
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$968M
$16.7K ﹤0.01%
1,946
-3,343
-63% -$32.1K
RNAC icon
12675
CALL
Cartesian Therapeutics
RNAC
$267M
$16.6K ﹤0.01%
523
-200
-28% -$6.68K

Similar funds

Citadel Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Citadel Advisors held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Citadel Advisors's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Citadel Advisors's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Citadel Advisors added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Citadel Advisors's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Citadel Advisors fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Citadel Advisors's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Citadel Advisors opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Citadel Advisors's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.